Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  ISIS Pharmaceuticals, Inc.    ISIS

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 284 M
EBIT 2015 -37,7 M
Net income 2015 -73,4 M
Debt 2015 -
Yield 2015 -
Sales 2016 259 M
EBIT 2016 -135 M
Net income 2016 -170 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
Capi. / Sales 2015 13,9x
Capi. / Sales 2016 15,3x
Capitalization 3 946 M
More Financials
Company
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery.It operates through two segments: Drug Discovery & Development Operations and Akcea.The Drug Discovery & Development Operations segment provides drugs to treat a variety of health conditions,... 
Sector
Biotechnology & Medical Research
Calendar
02/11 | 08:30amPresentation
More about the company
Surperformance© ratings of ISIS Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ISIS PHARMACEUTICALS, INC.
02/04 ISIS PHARMACEUTICALS : Ionis Pharmaceuticals to Present at Upcoming Investor Con..
01/27 IONIS PHARMACEUTICALS : Akcea Therapeutics Appoints Louis St. L. O'Dea as Chief ..
01/21 IONIS PHARMACEUTICALS : Announces that GSK has Initiated a Phase 1 Study of IONI..
01/21 IONIS PHARMACEUTICALS : Revises 2015 Financial Guidance and Provides Pipeline Up..
01/21 IONIS PHARMACEUTICALS : Completes Target Enrollment for Nusinersen Phase 3 Study..
01/19 IONIS PHARMACEUTICALS : Akcea Therapeutics Appoints Louis St. L. O'Dea as Chief ..
01/14 IONIS PHARMACEUTICALS : to Present at the 34th Annual J.P. Morgan Healthcare Con..
01/14 IONIS PHARMACEUTICALS : Receives Orphan Drug Designation from the US FDA for ION..
More news
Sector news : Biotechnology & Medical Research - NEC
06:02pDJPanel Recommends FDA Approval of Remicade Knockoff
05:07p JOHNSON & JOHNSON : FDA panel backs lower-cost version of J&J's top-selling drug
09:22aDJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Biotechnology & Medical Research - NEC
4-Traders Strategies on ISIS PHARMACEUTICALS, INC. 
2014A resistance as obstacle
More Strategies
News from SeekingAlpha
2015 Game Plan For The Week - Cramer's Mad Money (12/18/15)
2015 PREMARKET BIOTECH DIGEST : Portola's Milestone, Shkreli Resigns, BioMarin DMD Dr..
2015 Isis Pharma has had enough, name changed to Ionis Pharmaceuticals
2015 Bear Afoot? No Recession Needed For A Possible Sighting
2015 PREMARKET BIOTECH DIGEST : Gilead's Upside, Shire-Baxalta Deal, ARIAD Lowers Gui..
Comments 
Advertisement
Chart ISIS PHARMACEUTICALS, INC.
Duration : Period :
ISIS Pharmaceuticals, Inc. Technical Analysis Chart | ISIS | US4643301090 | 4-Traders
Full-screen chart
Technical analysis trends ISIS PHARMACEUTIC...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions